Cyclocryotherapy applied at the 3 o’clock and 9 o’clock positions combined with anti-VEGF injections for advanced neovascular glaucoma
Authors:
- 1 July 2025
- journal article
- research article
- Published by Springer Nature in International Ophthalmology
- Vol. 45 (1) , 1-12
Abstract
Objective This study aimed to investigate the efficacy of cyclocryotherapy applied at the 3 o’clock and 9 o’clock positions in combination with intravitreal anti-vascular endothelial growth factor (VEGF) injections in patients with advanced neovascular glaucoma (NVG). Methods Medical records of patients diagnosed with NVG who underwent cyclocryotherapy at the 3 o’clock and 9 o’clock positions combined with intravitreal anti-VEGF injections between January 2021 and January 2023 were retrospectively reviewed. Baseline and follow-up data including intraocular pressure (IOP), best-corrected visual acuity, perioperative pain scores using numeric rating scale, intraocular cytokines levels, and surgical complications, were analyzed. A successful surgical outcome was defined as an IOP below 21 mmHg with at least a 30% reduction from baseline. Results A total of 20 eyes from 20 patients were included. Elevated levels of several inflammatory mediators and angiogenic cytokines were detected in aqueous and vitreous samples. Pain scores significantly decreased scores at one month postoperatively (0.5±0.9) compared to preoperative values (6.2±3.0) (P<0.001). At the 3-month follow up, the mean IOP was 26.4±15.9 mmHg, representing a 39.0% reduction from baseline (43.2±10.6 mmHg) (P=0.003). At the final follow-up visit (mean duration 13.3±4.5 months), the mean IOP was 26.6±15.2 mmHg, corresponding to a 38.4% reduction from baseline. No cases of anterior segment ischemia or phthisis bulbi were documented during the follow-up period. The surgical success rate was 55% at 3 months and 60% at the final follow-up. Conclusions Cyclocryotherapy applied at the 3 o’clock and 9 o’clock position combined with anti-VEGF treatment presents a potential treatment alternative for advanced NVG. Further research is needed to validate its long-term efficacy and safety profile.Keywords
Funding Information
- Funding from the Shantou Science and Technology Plan Project (221113086496943)
- Funding from the Shantou Famous Doctor's Studio
This publication has 40 references indexed in Scilit:
- Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging OptionsAdvances in Therapy, 2018
- Autonomic Control of the Eye2014
- Ciliary blood flow and aqueous humor productionProgress in Retinal and Eye Research, 2011
- Trabeculectomy with Mitomycin C for Neovascular Glaucoma: Prognostic Factors for Surgical FailureAmerican Journal of Ophthalmology, 2009
- New perspectives in aqueous humor secretion and in glaucoma: The ciliary body as a multifunctional neuroendocrine glandProgress in Retinal and Eye Research, 2007
- Cyclocryotherapy in the Treatment of Advanced GlaucomaOphthalmology, 1985
- The contribution of blood flow by the anterior ciliary arteries to the anterior segment in the primate eyeExperimental Eye Research, 1980
- Anterior Segment Ischemia After CyclocryotherapyAmerican Journal of Ophthalmology, 1977
- Antiglaucomatous CycloanemizationAmerican Journal of Ophthalmology, 1966
- SURGICAL INTERVENTION ON THE CILIARY BODYJAMA, 1950